OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on October 3, 2016. The report addresses Item 8.01 (Other Events) regarding the status of the Company's 3.0% Convertible Senior Notes due 2033.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data. Specific metrics disclosed include:
- Outstanding Debt: $32.2 million in 3.0% Convertible Senior Notes due 2033.
- Stock Price Trigger: The closing price per share exceeded $9.19 (130% of the conversion price of $7.07) for at least 20 of 30 consecutive trading days during the quarter ended September 30, 2016.
- Conversion Rate: 141.4827 shares of Common Stock per $1,000 principal amount of Notes, plus applicable additional shares under early conversion provisions.
Material Changes
The primary material change is the confirmation that the conversion right for the Notes has been extended through December 31, 2016. This extension follows the same trigger conditions met in the quarters ended March 31, 2015, June 30, 2015, September 30, 2015, December 31, 2015, March 31, 2016, and June 30, 2016. The Company has elected to satisfy any conversion obligations in shares of common stock.
Outlook, Risks, and Management Commentary
The Notes may remain convertible beyond December 31, 2016, if specified conditions in the Indenture are satisfied during future measurement periods. Wells Fargo Bank, National Association serves as the trustee and conversion agent. The filing does not contain forward-looking guidance on revenue or earnings, nor does it detail specific risks beyond the mechanics of the note conversion.
Key Facts for Investor Verification
- Verify the current trading price of OPKO Health common stock relative to the $7.07 conversion price to assess dilution risk.
- Confirm the total principal amount of $32.2 million outstanding and the potential share issuance upon conversion.
- Review the Indenture dated January 30, 2013, for details on early conversion provisions and additional share calculations.
- Monitor future measurement periods to determine if conversion rights extend beyond December 31, 2016.